Statsure Diagnostic Systems, Inc. - Current report filing (8-K)
16 Mayo 2008 - 1:59PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the
Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported): May 16, 2008
StatSure
Diagnostic Systems, Inc.
(Exact
name of Registrant as specified in its charter)
(State
or
other jurisdiction of incorporation)
|
|
|
|
|
|
|
000-21284
|
|
|
|
91-1549305
|
|
|
|
|
|
|
|
(Commission
|
|
|
|
(IRS
Employer
|
|
File
Number)
|
|
|
|
Identification
No.)
|
|
|
|
|
|
|
|
1881
Worcester Rd. #200, Framingham, MA.
|
|
01701
|
|
|
|
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(Registrant’s
telephone number, including area code)
Saliva
Diagnostic Systems, Inc.
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM
5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
The
Company announced that effective July 1, 2008, Mr. Steve M. Peltzman, Chairman
of the Board and Chief Executive Officer, and Mr. D. Bruce Pattison, President,
Chief Operating Officer and Director, have resigned. Messrs Peltzman and
Pattison, have indicated that they will enter into Consulting Agreements
with
StatSure. In addition, Mr. Richard Woodrich has resigned as
Director. Concurrently, the Board elected Mr. Moishe Bodner, currently Vice
President of the Company, as Chief Executive Officer and Director, and Mr.
Leo
Ehrlich, the current Chief Financial Officer and Director, was elected as
the
President, Chief Operating Officer effective July 1, 2008.
ITEM
7.01. REGULATION FD DISCLOSURES.
On
March
20, 2008, the Company issued a press release titled “StatSure Diagnostic
Systems, Inc. Announces First Quarter Revenues And Management Changes.” A copy
of the press release is furnished herewith as Exhibit 99.1.
In
accordance with General Instruction B.2 of Form 8-K, the information in Item
7.01 and Exhibits 99.1 and 99.2 in this Current Report on Form 8-K shall
not be
deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934, nor shall it be deemed incorporated by reference in any
filing. This Current Report on Form 8-K does not constitute a
determination of whether any information included herein is
material.
ITEM
9.01. FINANCIAL STATEMENTS AND EXHIBITS.
Exhibit 99.1
- Press Release titled “StatSure Diagnostic Systems, Inc. Announces First
Quarter Revenues And Management Changes” dated May 16,
2008.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
|
|
StatSure
Diagnostic Systems, Inc.
|
|
|
|
|
|
|
Date:
May
16, 2008
|
By:
|
/s/
Leo Ehrlich
|
|
|
|
|
Leo
Ehrlich
|
|
|
|
|
Chief
Financial Officer
|
|
StatSure Diagnostic Syst... (CE) (USOTC:SSUR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
StatSure Diagnostic Syst... (CE) (USOTC:SSUR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
